What is a gonorrhea test? Gonorrhea is one of the most common sexually transmitted diseases (STDs). It is a bacterial infection spread through vaginal, oral, or anal sex with an infected person. It can also be spread from a pregnant woman to her baby during childbirth. Gonorrhea can infect both men and women. It is […]Continue Reading ...
WALTHAM, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) — Entasis Therapeutics (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced that The New England journal of Medicine (NEJM) published results from a Phase 2 clinical trial evaluating the safety and efficacy of zoliflodacin in patients with uncomplicated gonorrhea. […]Continue Reading ...
An investigational oral antibiotic called zoliflodacin was well-tolerated and successfully cured most cases of uncomplicated gonorrhea when tested in a Phase 2 multicenter clinical trial, according to findings published today in the New England Journal of Medicine. The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health, sponsored […]Continue Reading ...
There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance. BUSM researchers (in collaboration with University of Toronto researchers) have been investigating the use of animal models of gonorrhea, to study how the infection evolves and for potential use to determine the efficacy […]Continue Reading ...
July 27, 2018 Critical Discovery Comes as Antibiotic-Resistant ‘Super Gonorrhea’ Spreads Good news in the battle against the growing threat of drug-resistant “super gonorrhea”: Researchers at the University of Virginia School of Medicine and their collaborators in the United Kingdom have discovered a new way that the bacteria that cause gonorrhea resist the body’s immune […]Continue Reading ...
May 16, 2018 The first European-wide genomic survey of gonorrhea has mapped antibiotic resistance in this sexually transmitted disease throughout the continent. Researchers at The Centre for Genomic Pathogen Surveillance (CGPS), the Wellcome Sanger Institute, European Centre for Disease Control, and their collaborators also showed that using DNA sequencing data they could accurately determine antibiotic […]Continue Reading ...
March 30, 2018 Every year, more than 100 million people worldwide develop the sexually transmitted disease gonorrhea, with health consequences such as infertility, transmission of the disease to newborn babies, and increased risk of HIV infections. There has been a 63 percent rise in gonorrhea in Australia over the past five years. Gonorrhea is caused […]Continue Reading ...
A phase 2 clinical trial led by Stephanie N. Taylor, MD, Professor of Medicine and Microbiology in the Section of Infectious Diseases at LSU Health New Orleans School of Medicine, has found that a new antibiotic effectively treats uncomplicated urogenital and rectal gonorrhea infections in a single oral dose. Results are published in the November […]Continue Reading ...
TUESDAY, Sept. 4, 2018 — Nearly 2.3 million cases of chlamydia, gonorrhea, and syphilis were diagnosed in the United States in 2017, marking a fourth consecutive year of sharp increases in these sexually transmitted diseases (STDs), according to a report published by the U.S. Centers for Disease Control and Prevention. Based on preliminary data for […]Continue Reading ...
Neisseria gonorrhea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP). This threatens the effectiveness of the currently recommended dual therapy regimen for gonorrhoea. Overall, the rates of resistance to cefixime, ceftriaxone and azithromycin […]Continue Reading ...
May 17, 2018 Can whole genome sequencing illustrate changes in drug susceptibility of gonorrhea to antimicrobials used for treatment and so help to define more effective treatment regimens? The first study of this kind within an international surveillance program for sexually transmitted infections shows distribution of drug-resistant gonorrhea strains across Europe. The study results are […]Continue Reading ...
CARB Fact Sheet (February 15, 2018) Gonococcal Isolate Surveillance Project (GISP) Profiles 2015 (June 1, 2017) AR Investment Map This interactive tool shows CDC’s key investments to combat antibiotic resistance (AR), including resistant gonorrhea, across the nation. Blog by NCHHSTP Director: What Healthcare Providers Can Do to Slow Gonorrhea’s Growing Resistance to First-line Antibiotics Combating the […]Continue Reading ...
WEDNESDAY, April 4, 2018 — Americans should expect that a super-resistant form of gonorrhea like that found in the United Kingdom will soon reach these shores, health experts say. Earlier this year, doctors diagnosed a man in England with a case of gonorrhea that could not be cured with antibiotics commonly deployed against the sexually […]Continue Reading ...
A man from United Kingdom has acquired a gonorrhea infection with bacteria that is resistant to most antibiotics used commonly against it. The man has a regular sexual partner but picked up this superbug from a sexual encounter with a partner in south-east Asia earlier this year.Continue Reading ...
- Biologist uses new grant to find ways to eliminate schistosomiasis
- Bag-mask ventilation to help patients breathe during intubation prevents complications
- AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
- Nature versus nurture and addiction
- New website connects researchers with data experts, resources | News Center
- Today’s Concerns About Drug Prices Echo The Past
- CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
- Study finds out similarity in function between healthy retina cell and tumor cell
- CWRU awarded NIH grant to identify effective treatments for intimate partner violence
- Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
- Scientists discover new type of immune cells that are essential for forming heart valves
- Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
- Genetic defect linked to pediatric liver disease identified
- New cellular atlas could provide a deeper insight into blinding diseases
- Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
- Innovative compound offers a new therapeutic approach to treat multiple sclerosis
- $1.5 million grant to develop opioid treatment program for jail detainees
- FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
- Most Hip, Knee Replacements Last Decades, Study Finds
- Wellness problems prevalent among ob-gyn residents